ENLT vs. VRNA

Last updated Jun 9, 2026

ENLT (Enlight Renewable Energy Ltd. Ordinary Shares) and VRNA (Verona Pharma plc) are both stocks. ENLT operates in Utilities - Renewable (Utilities), while VRNA operates in Biotechnology (Healthcare). At a 0.09 correlation, their price movements are largely independent.

Performance

ENLT vs. VRNA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Enlight Renewable Energy Ltd. Ordinary Shares (ENLT) and Verona Pharma plc (VRNA). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

ENLT

• 1D: 4.48%
• 1M: 5.03%
• YTD: 109.11%
• 6M: 137.83%
• 1Y: 382.54%
• 3Y*: 69.79%
• 5Y*: —
• 10Y*: —

VRNA

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

ENLT vs. VRNA - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023
ENLT Enlight Renewable Energy Ltd. Ordinary Shares	109.11%	163.61%	-9.90%	6.93%
VRNA Verona Pharma plc	0.00%	130.21%	133.60%	-11.61%

Correlation

The correlation between ENLT and VRNA is -0.03, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	-0.03
Correlation (3Y) Calculated over the trailing 3-year period	0.10
Correlation (All Time) Calculated using the full available price history since Feb 10, 2023	0.09

The correlation between ENLT and VRNA shifts across timeframes, from -0.03 (1 year) to 0.10 (3 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap ENLT : $13.94B VRNA : $9.72B
EPS ENLT : $0.68 VRNA : -$0.69
PS Ratio ENLT : 16.15 VRNA : 57.97
PB Ratio ENLT : 6.57 VRNA : 34.92
Total Revenue (TTM) ENLT : $813.08M VRNA : $167.65M
Gross Profit (TTM) ENLT : $446.15M VRNA : $159.52M
EBITDA (TTM) ENLT : $670.45M VRNA : -$40.86M

Return for Risk

ENLT vs. VRNA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ENLT

ENLT Risk / Return Rank: 99
ENLT Sharpe Ratio Rank: 100
ENLT Sortino Ratio Rank: 98
ENLT Omega Ratio Rank: 98
ENLT Calmar Ratio Rank: 99
ENLT Martin Ratio Rank: 100

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ENLT vs. VRNA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Enlight Renewable Energy Ltd. Ordinary Shares (ENLT) and Verona Pharma plc (VRNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	ENLT	VRNA	Difference
Sharpe ratio: Return per unit of total volatility	7.22	—	—
Sortino ratio: Return per unit of downside risk	5.43	—	—
Omega ratio: Gain probability vs. loss probability	1.72	—	—
Calmar ratio: Return relative to maximum drawdown	21.44	—	—
Martin ratio: Return relative to average drawdown	73.16	—	—
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

Sharpe Ratios by Period

	ENLT	VRNA	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	7.22	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	1.49	—	—

Drawdowns

Drawdown Indicators

	ENLT	VRNA	Difference
Max Drawdown Largest peak-to-trough decline	-39.32%	—	—
Max Drawdown (1Y) Largest decline over 1 year	-17.98%	—	—
Max Drawdown (3Y) Largest decline over 3 years	-39.32%	—	—
Current Drawdown Current decline from peak	-11.51%	—	—
Average Drawdown Average peak-to-trough decline	-11.88%	—	—
Ulcer Index Depth and duration of drawdowns from previous peaks	5.26%	—	—

Volatility

Volatility by Period

	ENLT	VRNA	Difference
Volatility (1M) Calculated over the trailing 1-month period	21.08%	—	—
Volatility (6M) Calculated over the trailing 6-month period	43.80%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	53.52%	—	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	44.44%	—	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	44.44%	—	—

Dividends

ENLT vs. VRNA - Dividend Comparison

Neither ENLT nor VRNA has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

ENLT vs. VRNA - Profitability Comparison

The chart below illustrates the profitability comparison between Enlight Renewable Energy Ltd. Ordinary Shares and Verona Pharma plc over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

ENLT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Enlight Renewable Energy Ltd. Ordinary Shares reported a gross profit of 112.21M and revenue of 156.49M. Therefore, the gross margin over that period was 71.7%.

VRNA - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Verona Pharma plc reported a gross profit of 71.68M and revenue of 75.14M. Therefore, the gross margin over that period was 95.4%.

ENLT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Enlight Renewable Energy Ltd. Ordinary Shares reported an operating income of 81.63M and revenue of 156.49M, resulting in an operating margin of 52.2%.

VRNA - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Verona Pharma plc reported an operating income of 9.69M and revenue of 75.14M, resulting in an operating margin of 12.9%.

ENLT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Enlight Renewable Energy Ltd. Ordinary Shares reported a net income of 24.07M and revenue of 156.49M, resulting in a net margin of 15.4%.

VRNA - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Verona Pharma plc reported a net income of 8.69M and revenue of 75.14M, resulting in a net margin of 11.6%.

Frequently Asked Questions

Can I hold both ENLT and VRNA in my portfolio?

ENLT and VRNA have a correlation of -0.03, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.